Edition:
United States

Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

49.40TWD
21 Jul 2017
Change (% chg)

NT$1.05 (+2.17%)
Prev Close
NT$48.35
Open
NT$48.40
Day's High
NT$49.70
Day's Low
NT$48.05
Volume
482
Avg. Vol
328,865
52-wk High
NT$86.80
52-wk Low
NT$48.05

3176.TWO

Chart for 3176.TWO

About

MEDIGEN BIOTECHNOLOGY CORP. is engaged in the research and development of new drugs and the testing of nucleic acids. It involves in the licensing of technologies, the provision of technical services and the testing of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents,... (more)
No analyst recommendations are available for 3176.TWO.

Overall

Beta: 1.03
Market Cap(Mil.): NT$6,705.44
Shares Outstanding(Mil.): 138.69
Dividend: --
Yield (%): --

Financials

  3176.TWO Industry Sector
P/E (TTM): -- 215.12 15.95
EPS (TTM): -4.08 -- --
ROI: -29.27 -7.79 -8.24
ROE: -24.46 -9.19 -7.87

Earnings vs. Estimates